BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation - Trial NCT05813132
Access comprehensive clinical trial information for NCT05813132 through Pure Global AI's free database. This phase not specified trial is sponsored by Rehab Werida and is currently Recruiting. The study focuses on Lymphoma. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rehab Werida
Damanhour University
Timeline & Enrollment
N/A
Dec 01, 2022
Dec 31, 2023
Primary Outcome
Incidence of Side Effects.
Summary
The proposed research aims to compare between BeEAM standard regimen and CEM as conditioning
 regimen in lymphoma patients in safety profile& toxicity, infections (Febrile neutropenia)
 during transplant, time to engraftment (recovery not neutropenic), Length of stay at
 hospital, time to relapse, and other complications.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05813132
Non-Device Trial